Freebird Partners

Freebird Partners is a private investment firm based in Houston, Texas, that executes direct investments and acquires ownership stakes across the energy, biotechnology, and renewable technology sectors. The organization operates primarily within the private equity landscape, generating financial returns by securing significant equity positions in specialized middle-market companies, including traditional oilfield services and emerging therapeutics firms. Guided by a leadership team that includes key executive Charles Cherington, the firm actively manages its targeted investment portfolio to maximize shareholder value. As part of its biotechnology strategy, the firm currently maintains a 10% ownership stake in the portfolio company Ernexa Therapeutics Inc. Regulatory disclosures from April 2023 verify this specific equity position, noting that there were zero insider transactions executed by the firm over the subsequent 18 months. Freebird Partners was founded in 2002 by Curtis W. Huff.